Regulatory and Washington

ALEXANDRIA, Va. – Ensuring fair compensation and a level playing field are the chief concerns for community pharmacy operators as the 115th Congress begins their deliberations, according to the latest National Community Pharmacists Association member survey.

ARLINGTON, Va. – Provider status is back on the Congressional menu as the Pharmacy and Medically Underserved Areas Enhancement Act (S. 109) was reintroduced Thursday with the bipartisan original co-sponsorship of more than one-quarter of the U.S. Senate. The return of that critical piece of legislation in the U.S. House of Representatives also is anticipated shortly.

Could this be the year?

WASHINGTON, D.C. — The U.S. House of Representatives on Friday followed its U.S. Senate counterparts a week earlier, passing a budget resolution to draft a repeal bill that could overhaul or repeal the Affordable Care Act, otherwise known as Obamacare.

“This is a critical first step toward delivering relief to Americans who are struggling under this law,” Speaker Paul D. Ryan (R-Wis.) said.

ATLANTA — In what may be a serendipitous turn of events, on the same day the Senate re-introduced provider status legislation, the Centers for Disease Control and Prevention issued a report outlining the disparities between medically underserved communities in rural areas vs. their urban center counterparts.

WASHINGTON, D.C. – The Natural Products Association on Wednesday formed the Supplement Safety and Compliance Initiative, bringing together some of the largest retailers of natural products and supplements, including GNC and Walmart, on self-regulating the sale of VMS products.

ALEXANDRIA, Va. – The National Community Pharmacists Association on Wednesday reached out to Republican congressional leaders to provide the community pharmacist perspective on repeal and replacement of the Affordable Care Act and potential Medicaid changes, the association stated.

WASHINGTON — The Consumer Healthcare Products Association on Wednesday applauded the introduction of bipartisan, bicameral legislation in the U.S. Congress that would restore the ability of consumers to use their tax-preferred flexible spending arrangements and health savings accounts to purchase over-the-counter medicines. The legislation, “Restoring Access to Medication Act (RAMA) of 2017” (H.R. 394 and S. 85), was introduced in the Senate by Sens. Pat Roberts, R-Kan., and Heidi Heitkamp, D-N.D., and in the U.S. House by Reps.